Schedule 13G ownership disclosure

AVANIR PHARMACEUTICALS

Security class unavailable · CUSIP: 05348P401

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
6,575,201
Percent of class
3.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001041885-14-000036
Form type
SC 13G/A
Filer
AVANIR PHARMACEUTICALS, INC.
CIK
CIK 858803
Filed
Sep 12, 2014
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub